AmerisourceBergen Corporation

Chesterbrook, USA

AmerisourceBergen is a global pharmaceutical sourcing and distribution services company that provides drugs and healthcare solutions to healthcare providers, manufacturers, and patients worldwide.

CCI Score

-41.66

0.02% April 18

Latest Event

AmerisourceBergen Corporate PAC Expenditures Reported

The article outlines AmerisourceBergen Corporation's PAC expenditures for the 2023-2024 election cycle as reported by OpenSecrets. The disclosed spending data highlights the firm’s political financial activity, raising concerns over the potential influence this funding may exert on democratic processes.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: PVH

Columbia

U-Haul
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

TOADIE

AmerisourceBergen Corporation is currently rated as a Toadie.

-30 to -44 CCI Score

Companies scoring in this range actively seek to please authoritarian regimes. They offer proactive support and assistance in exchange for preferential treatment, compromising ethical standards for business gains and political favor.

Latest Events

JAN

01

2024

AmerisourceBergen Corporate PAC Expenditures Reported
-35.13

The article outlines AmerisourceBergen Corporation's PAC expenditures for the 2023-2024 election cycle as reported by OpenSecrets. The disclosed spending data highlights the firm’s political financial activity, raising concerns over the potential influence this funding may exert on democratic processes.
-40

Political Contributions and Lobbying Efforts

March 28

Reporting on AmerisourceBergen's PAC expenditures suggests significant corporate involvement in political financing. Such political contributions can be seen as amplifying corporate influence in elections, which from a left-leaning anti-fascist perspective raises concerns about fostering policies that may undermine worker rights and community interests.

AmerisourceBergen Corp PAC Expenditures • OpenSecrets
NOV

09

2023

Teamsters Demand Accountability Over Opioid Sales Practices
-51.94

At a national meeting in Las Vegas, the International Brotherhood of Teamsters announced plans to challenge AmerisourceBergen by demanding an internal investigation into its sales practices and a revision of executive compensation metrics to include compliance and integrity measures. This protest comes amid longstanding concerns over the company’s role in distributing opioids and previous DEA settlements over questionable orders.
-60

Business Practices and Ethical Responsibility

March 28

The union’s demands for an independent investigation into AmerisourceBergen’s sales practices and the call to tie executive compensation to compliance highlight serious concerns over the company’s ethical business practices. Given the company’s history of settling DEA cases and its significant role in the opioid crisis, this event reflects negative business practices that contribute to broader public health and community harm.

Teamsters go after drug wholesaler AmerisourceBergen after opioid crisis hits their homes
OCT

05

2023

DOJ Sues AmerisourceBergen Over Opioid Reporting Failures
-68.59

The U.S. Justice Department has filed a lawsuit against AmerisourceBergen, alleging that the company repeatedly failed to report suspicious opioid orders over the past decade. This alleged systematic neglect of its reporting obligations is claimed to have prioritized profits over public safety, contributing to the opioid crisis with severe public health consequences.
-80

Business Practices and Ethical Responsibility

March 28

AmerisourceBergen is accused of a systemic failure to report suspicious opioid orders, effectively putting profit motives above public safety. This breach of ethical business practices has contributed to the opioid epidemic, representing a severe disregard for legal and moral obligations.

Justice Department sues pharma distributor AmerisourceBergen over opioid orders
OCT

01

2023

Investigation Urged Over Anticompetitive Distribution Practices
-56.15

Senator Tammy Duckworth has called on the FTC to investigate AmerisourceBergen for allegedly using its market dominance to restrict the distribution of brand name Mifepristone to retail pharmacies, potentially to maximize profits at the expense of consumer choice and reproductive rights.
-70

Business Practices and Ethical Responsibility

March 28

AmerisourceBergen is accused of engaging in unfair and deceptive business practices by potentially using its exclusive position as the sole distributor of Mifepristone to selectively restrict sales to retail pharmacies, thereby limiting competition and consumer access. This behavior undermines ethical business practices and harms vulnerable patient populations, particularly those seeking reproductive healthcare.

Duckworth Urges FTC to Investigate Pharmaceutical Sourcing Giant for Potential Anticompetitive, Unfair and Deceptive Distribution of Federally-Approved Medication
-60

Economic and Structural Influence

March 28

The alleged strategy of using monopolistic power to serve only specific customer groups undermines market fairness and structural economic balance. By potentially limiting access to a federally approved medication and constraining competition among retail pharmacies, the company exhibits problematic economic behavior that can exacerbate inequalities in healthcare access.

Duckworth Urges FTC to Investigate Pharmaceutical Sourcing Giant for Potential Anticompetitive, Unfair and Deceptive Distribution of Federally-Approved Medication
JAN

01

2023

AmerisourceBergen Lobbying Spending in 2023
-23.84

AmerisourceBergen Corporation spent $515,000 on lobbying efforts during 2023, as reported by OpenSecrets. The funding is part of its ongoing political activities which may influence policy-making processes.
-30

Political Contributions and Lobbying Efforts

March 28

The report indicates that AmerisourceBergen Corporation spent $515,000 on lobbying in 2023. Such political spending raises concerns about corporate influence over public policy, potentially aligning with establishment interests that risk undermining democratic accountability. From an anti-authoritarian perspective, this level of lobbying investment may contribute to the corporate entanglement with political power structures.

AmerisourceBergen Corp Lobbying Profile - OpenSecrets
NOV

01

2022

AmerisourceBergen PAC Contribution Event
-23.45

AmerisourceBergen Corp contributed $255,500 to federal candidates during the 2021-2022 election cycle through its PAC, a move that raises concerns about corporate influence on democratic processes.
-30

Political Contributions and Lobbying Efforts

March 28

The company's PAC contribution totaling $255,500 to federal candidates represents a use of corporate funds to influence the political process. From an anti-fascist perspective, such contributions risk aligning corporate interests with political outcomes that may undermine progressive reforms and democratic accountability, thereby warranting a negative score.

AmerisourceBergen Corp PAC Contributions to Federal Candidates • OpenSecrets
DEC

31

2020

AmerisourceBergen Lobbying Spending in 2020
-32.52

AmerisourceBergen Corporation spent $2,710,000 on lobbying in 2020, as reported by OpenSecrets. This substantial expenditure illustrates the company's active efforts to influence political decision-making, raising concerns about corporate interference in democratic processes.
-50

Political Contributions and Lobbying Efforts

March 28

The reported lobbying expenditure of $2,710,000 in 2020 signals significant corporate effort to shape policymaking. Such spending can contribute to an imbalance of power that favors corporate interests over grassroots democracy, undermining democratic accountability and transparency—key concerns from an anti-fascist perspective.

AmerisourceBergen Corp Lobbying Profile • OpenSecrets